Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2077-2081
Published online before print September 22, 2005, doi: 10.1161/01.STR.0000183617.54752.69
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/10/2077    most recent
01.STR.0000183617.54752.69v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jood, K.
Right arrow Articles by Jern, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jood, K.
Right arrow Articles by Jern, C.
Related Collections
Right arrow Genetics of Stroke
Right arrow Fibrinolysis

(Stroke. 2005;36:2077.)
© 2005 American Heart Association, Inc.


Original Contributions

Fibrinolytic Gene Polymorphism and Ischemic Stroke

Katarina Jood, MD; Per Ladenvall, MD, PhD; Anna Tjärnlund-Wolf, PhD; Claes Ladenvall, MSc; Maria Andersson, MSc; Staffan Nilsson, PhD; Christian Blomstrand, MD, PhD Christina Jern, MD, PhD

From the Institute of Clinical Neuroscience (K.J., A.T.-W., C.L., C.B., C.J.) and the Clinical Experimental Research Laboratory, Cardiovascular Institute (P.L., M.A.), the Sahlgrenska Academy at Göteborg University; the Department of Clinical Genetics, Sahlgrenska University Hospital/Östra (A.T.-W., C.L., C.J.); the Department of Mathematical Statistics (S.N.), Chalmers University of Technology, Göteborg, Sweden.

Correspondence to Dr Christina Jern, Institute of Clinical Neuroscience, the Sahlgrenska Academy at Göteborg University, Sahlgrenska University Hospital/Sahlgrenska, S-413 45 Göteborg, Sweden. E-mail christina.jern{at}neuro.gu.se

Background and Purpose— The tissue-type plasminogen activator (tPA) –7351C>T and the plasminogen activator inhibitor type 1 (PAI-1) -675 4G >5G polymorphisms influence transcriptional activity. Both variants have been associated with myocardial infarction, with increased risk for the T and 4G allele, respectively. In this study we investigated the possible association between these polymorphisms, the respective plasma protein levels, and ischemic stroke.

Methods— In the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS), 600 patients with acute ischemic stroke aged 18 to 69 years and 600 matched community controls were recruited. Stroke subtype was determined using Trial of Org 10172 in Acute Treatment criteria.

Results— There were no associations between individual genetic variants and ischemic stroke. The multivariate-adjusted odds ratio for overall ischemic stroke was 1.11 (95% CI 0.87 to 1.43) for tPA T allele carriers, and 0.84 (95% CI, 0.64 to 1.11) for subjects homozygous for the PAI-1 4G allele. When genotypes were combined, a protective effect for the tPA CC/PAI-1 4G4G genotype combination was observed (odds ratio 0.65, 95% CI 0.43 to 0.98; P<0.05). Plasma levels of tPA and PAI-1 antigen at follow-up were independently associated with overall ischemic stroke. tPA-antigen differed by stroke subtype and was highest among those with large-vessel disease and cardioembolic stroke.

Conclusions— Neither the tPA –7351C>T nor the PAI-1 to 675 4G >5G polymorphism showed significant association with ischemic stroke. For the tPA CC/PAI-1 4G4G genotype combination, a protective effect was observed. Collectively, these results are consistent with a more complex role for tPA and PAI-1 in the brain as compared with the heart.


Key Words: ischemic stroke subtypes • plasminogen activator inhibitor type 1 • polymorphism • tissue-type plasminogen activator




This article has been cited by other articles:


Home page
Eur Respir JHome page
J. Suntharalingam, K. Goldsmith, V. van Marion, L. Long, C. M. Treacy, F. Dudbridge, M. R. Toshner, J. Pepke-Zaba, J. C. J. Eikenboom, and N. W. Morrell
Fibrinogen A{alpha} Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension
Eur. Respir. J., April 1, 2008; 31(4): 736 - 741.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
V Giedraitis, M Hedlund, L Skoglund, E Blom, S Ingvast, R Brundin, L Lannfelt, and A Glaser
New Alzheimer's disease locus on chromosome 8
J. Med. Genet., December 1, 2006; 43(12): 931 - 935.
[Abstract] [Full Text] [PDF]